IO Biotech, Inc. (IOBTQ) Net Equity Issued and Repurchased (2021)
IO Biotech's (IOBTQ) quarterly Net Equity Issued and Repurchased came in at $49.4 million in Q4 2021, down 24.91% on a QoQ basis from $65.7 million in Q1 2021.
IO Biotech, Inc. (IOBTQ) Net Equity Issued and Repurchased (2021) Analysis & Trends
IO Biotech (IOBTQ) has 1 years of Net Equity Issued and Repurchased data on file, last reported at $49.4 million in Q4 2021.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $49.4 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $115.1 million (changed N/A YoY) and the FY2021 annual result came in at $115.1 million, up 2150.1% from the prior year.
- Net Equity Issued and Repurchased fell to $49.4 million in Q4 2021, from $65.7 million in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $65.7 million in Q1 2021 to a low of $49.4 million in Q4 2021.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 49.37 Mn |
| Dec 31, 2021 | 49.37 Mn |
| Mar 31, 2021 | 65.75 Mn |
| Mar 31, 2021 | 65.75 Mn |